AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Gandara, DR Lara, PN Goldberg, Z Roberts, P Lau, DHM
Citation: Dr. Gandara et al., Neoadjuvant therapy for non-small cell lung cancer, ANTI-CANC D, 12, 2001, pp. S5-S9

Authors: Gandara, DR Edelman, MJ Lara, PN Lau, DHM
Citation: Dr. Gandara et al., Gemcitabine in combination with new platinum compounds: An update, ONCOLOGY-NY, 15(3), 2001, pp. 13-17

Authors: Lara, PN Higdon, R Lim, N Kwan, K Tanaka, M Lau, DHM Wun, T Welborn, J Meyers, FJ Christensen, S O'Donnell, R Richman, C Scudder, SA Tuscano, J Gandara, DR Lam, KS
Citation: Pn. Lara et al., Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment, J CL ONCOL, 19(6), 2001, pp. 1728-1733

Authors: Gandara, DR Lara, PN Goldberg, Z Lau, DHM
Citation: Dr. Gandara et al., Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non-small cell lung cancer: Focus on docetaxel, SEMIN ONCOL, 28(3), 2001, pp. 26-32

Authors: Edelman, MJ Gandara, DR Lau, DHM Lara, P Lauder, IJ Tracy, D
Citation: Mj. Edelman et al., Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel, CANCER, 92(1), 2001, pp. 146-152

Authors: Lau, DHM
Citation: Dhm. Lau, Inhibition of NF-kappa B sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis - Invited commentary, ANN THORAC, 70(3), 2000, pp. 937-937
Risultati: 1-6 |